Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,145 | -5,593 | -1,532 | 1,410 | -9 |
| Depreciation Amortization | 1,654 | 992 | 577 | 277 | 0 |
| Accounts receivable | 12,559 | 10,356 | 3,461 | 8,976 | N/A |
| Accounts payable and accrued liabilities | -2,936 | -3,274 | -1,877 | -3,836 | N/A |
| Other Working Capital | 11,683 | 10,474 | 3,911 | 8,083 | -1 |
| Other Operating Activity | -3,829 | -6,090 | -1,472 | -5,456 | 0 |
| Operating Cash Flow | $1,987 | $6,865 | $3,068 | $9,454 | $-10 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,944 | -8,582 | -5,354 | -1,890 | 0 |
| Investing Cash Flow | $-10,944 | $-8,582 | $-5,354 | $-1,890 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,841 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,296 | -143 | -92 | -46 | N/A |
| Common Stock Issued | 7 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 34,340 | 0 | 0 | 0 | 95 |
| Financing Cash Flow | $35,891 | $-143 | $-92 | $-46 | $95 |
| Beginning Cash Position | 12,610 | 12,610 | 12,610 | 12,610 | 0 |
| End Cash Position | 39,545 | 10,751 | 10,233 | 20,128 | 85 |
| Net Cash Flow | $26,935 | $-1,860 | $-2,378 | $7,518 | $85 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,987 | 6,865 | 3,068 | 9,454 | -10 |
| Capital Expenditure | -10,944 | -8,582 | -5,354 | -1,890 | N/A |
| Free Cash Flow | -8,957 | -1,717 | -2,286 | 7,563 | -10 |